Page last updated: 2024-11-04

sb 239063 and Cirrhosis

sb 239063 has been researched along with Cirrhosis in 1 studies

SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Boer, RA1
Pokharel, S1
Flesch, M1
van Kampen, DA1
Suurmeijer, AJ1
Boomsma, F1
van Gilst, WH1
van Veldhuisen, DJ1
Pinto, YM1

Other Studies

1 other study available for sb 239063 and Cirrhosis

ArticleYear
Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
    Journal of molecular medicine (Berlin, Germany), 2004, Volume: 82, Issue:10

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Atr

2004